CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter's five forces analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Surge in prevalence of cardiac arrhythmias
3.4.1.2.Rise in geriatric population.
3.4.1.3.Growth in preference for minimally invasive procedures

3.4.2.Restraint

3.4.2.1.High Cost of 3D Cardiac Mapping Systems

3.4.3.Opportunity

3.4.3.1.Rise in Preference for 3D Cardiac Mapping
3.4.3.2.Rise in the Healthcare Expenditure in China

3.5.Impact of government regulations on China 3d cardiac mapping market

CHAPTER 4:CHINA 3D CARDIAC MAPPING MARKET, BY TECHNOLOGY

4.1.Overview

4.1.1.Market size and forecast

4.2.Electroanatomical mapping

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region

4.3.Basket catheter mapping

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region

4.4.Real-time positional management (cardiac pathways) EP system

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region

CHAPTER 5:CHINA 3D CARDIAC MAPPING MARKET, BY END USER

5.1.Overview

5.1.1.Market size and forecast

5.2.Hospitals

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast

5.3.Clinics

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast

5.4.Diagnostics centers

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast

CHAPTER 6:COMPANY PROFILES

6.1.Abbott Laboratories

6.1.1.Company overview
6.1.2.Company snapshot
6.1.3.Operating business segments
6.1.4.Product portfolio
6.1.5.Business performance
6.1.6.Key strategic moves and developments

6.2.Acutus Medical

6.2.1.Company overview
6.2.2.Company snapshot
6.2.3.Operating business segments
6.2.4.Product portfolio
6.2.5.Key strategic moves and developments

6.3.MicroPort Scientific Corporation

6.3.1.Company overview
6.3.2.Company snapshot
6.3.3.Operating business segments
6.3.4.Product portfolio
6.3.5.Business performance.

6.4.Medtronic Plc.

6.4.1.Company overview
6.4.2.Company snapshot
6.4.3.Operating business segments
6.4.4.Product portfolio
6.4.5.Business performance
6.4.6.Key strategic moves and developments